TY - JOUR
T1 - Adiposity as a cause of cardiovascular disease
T2 - A Mendelian randomization study
AU - European Network for Genetic and Genomic Epidemiology (ENGAGE) consortium
AU - Hägg, Sara
AU - Fall, Tove
AU - Ploner, Alexander
AU - Mägi, Reedik
AU - Fischer, Krista
AU - Draisma, Harmen H.M.
AU - Kals, Mart
AU - De Vries, Paul S.
AU - Dehghan, Abbas
AU - Willems, Sara M.
AU - Sarin, Antti Pekka
AU - Kristiansson, Kati
AU - Nuotio, Marja Liisa
AU - Havulinna, Aki S.
AU - De Bruijn, Renée F.A.G.
AU - Ikram, M. Arfan
AU - Kuningas, Maris
AU - Stricker, Bruno H.
AU - Franco, Oscar H.
AU - Benyamin, Beben
AU - Gieger, Christian
AU - Hall, Alistair S.
AU - Huikari, Ville
AU - Jula, Antti
AU - Järvelin, Marjo Riitta
AU - Kaakinen, Marika
AU - Kaprio, Jaakko
AU - Kobl, Michael
AU - Mangino, Massimo
AU - Nelson, Christopher P.
AU - Palotie, Aarno
AU - Samani, Nilesh J.
AU - Spector, Tim D.
AU - Strachan, David P.
AU - Tobin, Martin D.
AU - Whitfield, John B.
AU - Uitterlinden, André G.
AU - Salomaa, Veikko
AU - Syvänen, Ann Christine
AU - Kuulasmaa, Kari
AU - Magnusson, Patrik K.
AU - Esko, Tõnu
AU - Hofman, Albert
AU - De Geus, Eco J.C.
AU - Lind, Lars
AU - Giedraitis, Vilmantas
AU - Perola, Markus
AU - Evans, Alun
AU - Ferriéres, Jean
AU - Virtamo, Jarmo
N1 - Publisher Copyright:
© The Author 2015; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
PY - 2015/5/27
Y1 - 2015/5/27
N2 - Background: Adiposity, as indicated by body mass index (BMI), has been associated with risk of cardiovascular diseases in epidemiological studies. We aimed to investigate if these associations are causal, using Mendelian randomization (MR) methods. Methods: The associations of BMI with cardiovascular outcomes [coronary heart disease (CHD), heart failure and ischaemic stroke], and associations of a genetic score (32 BMI single nucleotide polymorphisms) with BMI and cardiovascular outcomes were examined in up to 22 193 individuals with 3062 incident cardiovascular events from nine prospective follow-up studies within the ENGAGE consortium. We used random-effects meta-analysis in an MR framework to provide causal estimates of the effect of adiposity on cardiovascular outcomes. Results: There was a strong association between BMI and incident CHD (HR = 1.20 per SD-increase of BMI, 95% CI, 1.12-1.28, P = 1.9·10-7), heart failure (HR = 1.47, 95% CI, 1.35-1.60, P = 9·10-19) and ischaemic stroke (HR = 1.15, 95% CI, 1.06-1.24, P = 0.0008) in observational analyses. The genetic score was robustly associated with BMI (β = 0.030 SD-increase of BMI per additional allele, 95% CI, 0.028-0.033, P = 3·10-107). Analyses indicated a causal effect of adiposity on development of heart failure (HR = 1.93 per SD-increase of BMI, 95% CI, 1.12-3.30, P = 0.017) and ischaemic stroke (HR = 1.83, 95% CI, 1.05-3.20, P = 0.034). Additional cross-sectional analyses using both ENGAGE and CARDIoGRAMplusC4D data showed a causal effect of adiposity on CHD. Conclusions: Using MR methods, we provide support for the hypothesis that adiposity causes CHD, heart failure and, previously not demonstrated, ischaemic stroke.
AB - Background: Adiposity, as indicated by body mass index (BMI), has been associated with risk of cardiovascular diseases in epidemiological studies. We aimed to investigate if these associations are causal, using Mendelian randomization (MR) methods. Methods: The associations of BMI with cardiovascular outcomes [coronary heart disease (CHD), heart failure and ischaemic stroke], and associations of a genetic score (32 BMI single nucleotide polymorphisms) with BMI and cardiovascular outcomes were examined in up to 22 193 individuals with 3062 incident cardiovascular events from nine prospective follow-up studies within the ENGAGE consortium. We used random-effects meta-analysis in an MR framework to provide causal estimates of the effect of adiposity on cardiovascular outcomes. Results: There was a strong association between BMI and incident CHD (HR = 1.20 per SD-increase of BMI, 95% CI, 1.12-1.28, P = 1.9·10-7), heart failure (HR = 1.47, 95% CI, 1.35-1.60, P = 9·10-19) and ischaemic stroke (HR = 1.15, 95% CI, 1.06-1.24, P = 0.0008) in observational analyses. The genetic score was robustly associated with BMI (β = 0.030 SD-increase of BMI per additional allele, 95% CI, 0.028-0.033, P = 3·10-107). Analyses indicated a causal effect of adiposity on development of heart failure (HR = 1.93 per SD-increase of BMI, 95% CI, 1.12-3.30, P = 0.017) and ischaemic stroke (HR = 1.83, 95% CI, 1.05-3.20, P = 0.034). Additional cross-sectional analyses using both ENGAGE and CARDIoGRAMplusC4D data showed a causal effect of adiposity on CHD. Conclusions: Using MR methods, we provide support for the hypothesis that adiposity causes CHD, heart failure and, previously not demonstrated, ischaemic stroke.
KW - Body mass index
KW - Cardiovascular disease
KW - Epidemiology
KW - Mendelian randomization
UR - http://www.scopus.com/inward/record.url?scp=84936753519&partnerID=8YFLogxK
U2 - 10.1093/ije/dyv094
DO - 10.1093/ije/dyv094
M3 - Article
C2 - 26016847
AN - SCOPUS:84936753519
SN - 0300-5771
VL - 44
SP - 578
EP - 586
JO - International Journal of Epidemiology
JF - International Journal of Epidemiology
IS - 2
ER -